Issue link: https://www.e-digitaleditions.com/i/331259
AVAILABLE NOW at the Tablets & Capsules Bookstore. Audio and visual content provided on CD—$150. Share with colleagues! www.tabletscapsules.com Vivian Gray, V.A. Gray Consulting and Dissolution Technologies, Presenter Matthew Knopp, Editor of Tablets & Capsules, Moderater Dissolution methods of the modern pharmaceutical laboratory should exemplify the principles of Quality by Design (QbD). In this webinar, you'll learn how to develop discriminating dissolution methods that lead to clinically relevant specifi cations and meet global requirements. This presentation will also teach you method development principles based on BCS of immediate-release formulations and will discuss f2. It will also discuss the challenges of poorly soluble compounds and introduce DoE as a tool for challenging the discriminatory power of the method. W E B I N A R Method Development, including Design of Experiments (DoE) in Dissolution Testing Sourcebook_PBE-CCR 6/10/14 1:34 PM Page 72